Eurobio Scientific

Equities

ALERS

FR0013240934

Biotechnology & Medical Research

Real-time Euronext Paris 10:07:13 2024-04-19 am EDT 5-day change 1st Jan Change
14.64 EUR -1.35% Intraday chart for Eurobio Scientific -6.87% -11.06%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Eurobio Scientific: 2023 results down, share price falls CF
Eurobio Scientific Société anonyme acquired Alpha Biotech Ltd. CI
Eurobio Scientific: cancellation of treasury shares CF
OSE Immuno: collaboration agreement with GenDx CF
Eurobio Scientific Appoints Catherine Courboillet to the Board of Directors CI
Eurobio Scientific Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Eurobio Scientific Société anonyme(ENXTPA:ALERS) dropped from S&P Global BMI Index CI
Q-linea Shares Gain Amid Progress of French Distribution Deal MT
Eurobio Scientific Société anonyme acquired Diagnostic International Distribution SPA from Barbara Maffioli and Enrico Maffioli. CI
Q-linea Expands European Reach with Distribution Partnership in France MT
Q-linea AB Signs Distribution Partnership for ASTar Instrument and Consables for France with Eurobio Scientific CI
Eurobio Scientific Strikes Deal to Buy Italy's Diagnostic International Distribution MT
Eurobio Scientific Société anonyme signing of an agreement to acquire Diagnostic International Distribution SPA. CI
Global markets live: Agilent, Intuit, Palo Alto, Kohl's, Urban Outfitters... Our Logo
Eurobio Scientific Secures IVDR CE Marking for Diagnostic Tests MT
Eurobio Scientific Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022 CI
EchiumBio Takes 2% Stake in Eurobio Scientific MT
Eurobio Scientific's New CFO Formally Takes Office MT
Eurobio Scientific Obtains Distribution Rights For Pancreatic Cancer Diagnostic Test MT
Eurobio Scientific and Acobiom Announce the Signature of an Exclusive Commercial Agreement for the Distribution of A Diagnostic Test That Predicts Response to A Treatment for Pancreatic Cancer CI
France's Eurobio Scientific Closes $133 Million Purchase On Genome Diagnostics MT
Eurobio Scientific Société anonyme acquired Genome Diagnostics B.V. from from Ampersand Capital Partners and others. CI
Eurobio Scientific To Buy Genome Diagnostics For $137 Million MT
Eurobio Scientific Société anonyme agreed to acquire Genome Diagnostics B.V. from Ampersand Capital Partners and others for €135 million. CI
Eurobio Scientific Reports Revenue Results for the First Half of 2022 CI
Chart Eurobio Scientific
More charts
Eurobio Scientific is a key player in the field of specialty in vitro diagnostics. It is involved from research to manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, Eurobio Scientific has established its own distribution network and a portfolio of proprietary products in the molecular biology field. The group has approximately 286 employees, three production units based in the Paris region, in Germany and in the United States, and subsidiaries in Dorking in the United Kingdom, Sissach in Switzerland, Bünde in Germany and Utrecht in the Netherlands.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
14.84 EUR
Average target price
30 EUR
Spread / Average Target
+102.16%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALERS Stock
  4. News Eurobio Scientific
  5. Eurobio Scientific : Introduces Proprietary Antigen Self-Test Kit